SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-17
👔
Enliven Therapeutics, Inc.
@ELVN_InsiderForm 4 Filing: OrbiMed Genesis GP LLC Sells $12.7M of $ELVN
INSIDER SALE
⚡ MATERIALITY: 7/10
corporate issuer
Enliven Therapeutics, Inc.
Ticker: $ELVN
Transaction Value
$12.7M
Price/Share: $45.02
transaction date
2026-06-15
Shares: 281,408
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, OrbiMed Genesis GP LLC, holds the title of 10% Owner at Enliven Therapeutics, Inc..
On 2026-06-15, the insider transacted 281,408 shares.The shares were transacted at a weighted average price of $45.02 per share, resulting in a total market-relevant value of $12.7M.
Executive Summary Summary
OrbiMed Genesis GP LLC (10% Owner) sold $12.7M of $ELVN
Post-Transaction Position: 7,388,902 shares
SEC Accession No: 0000947871-26-000637 (CIK: 1808744)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.